Home › Hodgkin Lymphoma › Colorado › Aurora
Hodgkin Lymphoma clinical trials in Aurora, CO
4 studies for Hodgkin Lymphoma are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RecruitingObservational study
- Children's Hospital Colorado, Aurora
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
RecruitingPhase 1
- University of Colorado, Aurora
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecruitingObservational study
- Children's Hospital Colorado, Aurora
- University of Colorado Hospital, Aurora
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
RecruitingObservational study
- University of Colorado Hospital, Aurora
About Hodgkin Lymphoma
Hodgkin lymphoma is a type of lymphoma, cancer of the lymph system. It is serious but can usually be cured if found and treated early. Learn more.
More about Hodgkin Lymphoma on MedlinePlus
Hodgkin Lymphoma trials in other cities
- Houston, TX14 studies
- New York City, NY11 studies
- Baldwin Park, CA9 studies
- Boston, MA9 studies
- Miami, FL8 studies
- Memphis, TN7 studies
- Philadelphia, PA6 studies
- Greenburgh, NY5 studies
- Mountain View, CA5 studies
- Atlanta, GA5 studies
- Durham, NC4 studies
- Madison, WI4 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer27 studies
- Metastatic Cancer25 studies
- Ovarian Cancer25 studies
- Type 1 Diabetes23 studies
- Obesity21 studies
- Lung Cancer19 studies
- Prostate Cancer19 studies
- Heart Failure18 studies
- Melanoma18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.